Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Advances in Lung Cancer Biomarkers: Detection and Clinical Application
Review Article: Int J Inflam Cancer Integr Ther 2024, 11: 280
Breast Cancer Subtypes and their Associated Biomarkers: A Comprehensive Review
Review Article: Int J Inflam Cancer Integr Ther 2024, 11: 281
Prostate Cancer Biomarkers: Emerging Tools for Diagnosis and Prognosis
Review Article: Int J Inflam Cancer Integr Ther 2024, 11: 282
Colorectal Cancer: Novel Biomarkers and Their Role in Early Detection
Mini Review: Int J Inflam Cancer Integr Ther 2024, 11: 283
Pancreatic Cancer: Current Biomarkers and Future Directions
Short Communication: Int J Inflam Cancer Integr Ther 2024, 11: 284
Biomarkers in Ovarian Cancer: from Bench to Bedside
Short Communication: Int J Inflam Cancer Integr Ther 2024, 11: 285
Hematologic Cancers: Biomarkers and their Clinical Implications
Opinion: Int J Inflam Cancer Integr Ther 2024, 11: 286
Melanoma Biomarkers: Diagnostic and Therapeutic Implications
Opinion: Int J Inflam Cancer Integr Ther 2024, 11: 287
Gastroesophageal Cancer Biomarkers: Insights and Innovations
Perspective: Int J Inflam Cancer Integr Ther 2024, 11: 288
Bladder Cancer Biomarkers: Clinical Significance and Future Prospects
Perspective: Int J Inflam Cancer Integr Ther 2024, 11: 289
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals